JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB259058

Human PPP1R3C knockout HeLa cell lysate

Be the first to review this product! Submit a review

|

(0 Publication)

PPP1R3C KO cell lysate available now. KO validated by. Free of charge wild type control included. Knockout achieved by using CRISPR/Cas9, 1 bp deletion in exon2.

View Alternative Names

OTTHUMP00000020089, PP1 subunit R5, PPP1R5, PPR3C_HUMAN, PTG, Phosphatase 1, regulatory inhibitor subunit 5, Protein phosphatase 1 inhibitor 3C, Protein phosphatase 1 regulatory subunit 3C, Protein phosphatase 1 regulatory subunit 5, Protein targeting to glycogen, R5, protein phosphatase 1, regulatory (inhibitor) subunit 3C

1 Images
Sanger Sequencing - Human PPP1R3C knockout HeLa cell lysate (AB259058)
  • Sanger seq

Unknown

Sanger Sequencing - Human PPP1R3C knockout HeLa cell lysate (AB259058)

Homozygous : 1 bp deletion in exon2

Key facts

Cell type

HeLa

Species or organism

Human

Tissue

Cervix

Knockout validation

Sanger Sequencing

Mutation description

Knockout achieved by using CRISPR/Cas9, 1 bp deletion in exon2.

Disease

Adenocarcinoma

Product details

Knockout cell lysate achieved by CRISPR/Cas9.

REACH authorisation
Abcam has not and does not intend to apply for the REACH Authorisation of customers' uses of products that contain European Authorisation list (Annex XIV) substances.
It is the responsibility of our customers to check the necessity of application of REACH Authorisation, and any other relevant authorisations, for their intended uses.

Lysate preparation: Our lysates are made using RIPA buffer to which we add a protease inhibitor cocktail and phosphatase inhibitor cocktail (ratio: 300:100:10). This means that the protein of interest is denatured. If you require a native form of the protein please use the live cell version. Please refer to our lysis protocol for further details on how our lysates are prepared.

User storage instructions: Lyophilizate may be stored at 4°C. After reconstitution, store at -20°C for short-term storage or -80°C for long-term storage.

This product is subject to limited use licenses from The Broad Institute and ERS Genomics Limited, and is developed with patented technology. For full details of the limited use licenses and relevant patents please refer to our limited use license and patent pages.

What's included?

{ "values": { "1Kit": { "sellingSize": "1 Kit", "publicAssetCode":"ab259058-1Kit", "assetComponentDetails": [ { "size":"1 x 100 µg", "name":"Human PPP1R3C knockout HeLa cell lysate", "number":"AB259058-CMP01", "productcode":"" }, { "size":"1 x 100 µg", "name":"Human wild-type HeLa cell lysate", "number":"AB259058-CMP02", "productcode":"" } ] } } }

Properties and storage information

Gene name
PPP1R3C
Gene editing type
Knockout
Gene editing method
CRISPR technology
Knockout validation
Sanger Sequencing
Shipped at conditions
Ambient - Can Ship with Ice
Appropriate short-term storage conditions
-20°C
Appropriate long-term storage conditions
-20°C

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

PPP1R3C also known as protein phosphatase 1 regulatory subunit 3C is a regulatory subunit of protein phosphatase 1 (PP1). This protein has a mass of approximately 34 kDa. PPP1R3C is mainly expressed in skeletal muscle and liver tissues. It acts by modulating glycogen metabolism where it impacts glycogen synthesis and breakdown. This regulation is achieved through altering the activity of PP1 which dephosphorylates diverse biological substrates to control various cellular functions.
Biological function summary

The PPP1R3C protein binds to glycogen and PP1 forming a complex with these substrates. This interaction plays a role in the regulation of glucose homeostasis by controlling glycogen synthesis and breakdown. Such processes are important for energy storage and release in muscle and liver tissues. By integrating within this complex PPP1R3C influences the activity and localization of PP1 facilitating efficient glycogen regulation.

Pathways

PPP1R3C participates in critical pathways like glycogen metabolism and insulin signaling. The protein is closely associated with key metabolic proteins such as glycogen synthase. Within these pathways PPP1R3C modifies the enzymatic activity of its pathway partners to balance glucose levels in response to insulin. This involvement supports metabolic flexibility and energy management in response to dietary changes.

PPP1R3C connects to insulin resistance and type 2 diabetes where its altered function may disrupt normal glycogen metabolism. The protein's dysfunction impacts glucose homeostasis and insulin signaling pathway contributing to the pathophysiology of these metabolic diseases. Additionally PPP1R3C interacts with proteins like glycogen synthase which play significant roles in the metabolic disturbances seen in such disorders. Understanding these interactions helps in devising strategies for targeted therapeutic interventions.

Quality control

STR analysis

CSF1PO, D13S317, D7S820, D5S818, TH01, D16S539, TPOX

Cell culture

Biosafety level

EU: 2 US: 2

Adherent/suspension

Adherent

Gender

Female

Product protocols

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com